Austria’s Digital Pharmacy Retail: Market Statistics 2025
The Austrian pharmacy sector is experiencing a sustained shift towards digital retail channels. This analysis provides a data-driven overview of key market statistics and projections for 2025, detailing market volumes, growth drivers, player landscape, and consumer engagement within the digital segment.
Market Volume and Growth Trajectory
The digital retail segment of the Austrian pharmacy market continues its expansion, driven by evolving consumer preferences and increasing digital infrastructure adoption. QuantisIntel projects a significant increase in online sales volume for pharmaceutical and health-related products by 2025. This growth encompasses over-the-counter (OTC) medications, medical devices, dermocosmetics, and health supplements sold via online platforms.
The estimated market volume for digital pharmacy retail in Austria, excluding prescription medications due to current regulatory restrictions, is projected to reach substantial figures. Growth rates are influenced by factors such as broader e-commerce penetration, convenience demands, and the widening assortment available through online channels, including cross-border EU providers.
| Metric | 2023 Estimated Value | 2024 Estimated Value | 2025 Projected Value | Change (2024-2025) |
|---|---|---|---|---|
| Online Pharmacy Retail Volume | €185 Million | €210 Million | €245 Million | +16.7% |
| Online Penetration (of total) | 4.8% | 5.4% | 6.2% | +0.8 pp |
| User Penetration (Online) | 28.5% | 31.2% | 34.5% | +3.3 pp |
| Average Online Basket Size | €58.20 | €61.50 | €64.80 | +5.3% |
Note: Online Penetration refers to the share of total pharmacy retail revenue generated through online channels. User Penetration refers to the percentage of the Austrian online population that has purchased pharmacy products online at least once within a 12-month period.
The primary growth drivers for 2025 include continued digital literacy improvements across demographic segments, increased logistical efficiencies for last-mile delivery, and the strategic expansion of product ranges by established online pharmacy providers. The convenience factor remains a significant influence, particularly for routine purchases and specialized health products not always readily available in every physical Apotheke.
Online Pharmacy Player Landscape
The Austrian digital pharmacy retail landscape is characterized by a dual structure: the online presence of traditional brick-and-mortar pharmacies (Versandapotheken) and pure-play online pharmacies, often operating from other EU member states under the principle of free movement of goods.
Local Austrian pharmacies have increasingly established online storefronts, driven by the necessity to compete with larger European online platforms and to serve their existing customer base digitally. However, their market share in the pure online segment remains moderate compared to cross-border competitors, largely due to scale advantages and broader product assortments offered by the latter.
QuantisIntel’s analysis indicates the following approximate distribution of online sales volume by player type for 2024, projected to remain largely stable into 2025:
| Player Type | 2024 Estimated Market Share | 2025 Projected Market Share |
|---|---|---|
| Austrian Traditional Pharmacies (Online Sales) | 28% | 29% |
| EU Cross-Border Online Pharmacies | 65% | 64% |
| Other Retailers (e.g., Drogeriemärkte online) | 7% | 7% |
The dominance of EU cross-border online pharmacies is attributed to their historical head start in digital operations, often more competitive pricing structures for non-prescription items, and extensive product catalogs. Austrian pharmacies are improving their digital offerings, focusing on personalized advice, faster local delivery options, and integration with their physical locations (e.g., click & collect services). The “Other Retailers” category includes general e-commerce platforms and drugstores that offer a limited range of health and wellness products, typically excluding medicinal items.
Consumer Adoption and Product Preferences
Consumer behavior in the Austrian online pharmacy market demonstrates clear preferences for certain product categories and purchasing drivers. The convenience of 24/7 access, direct-to-home delivery, and often a broader selection are key motivators for online purchases.
Data from 2024 indicates that approximately 31.2% of the Austrian online population made at least one purchase from an online pharmacy within the year. This figure is projected to rise to 34.5% by the end of 2025, indicating a steady increase in digital channel acceptance for health-related purchases.
Top-selling product categories in the online pharmacy segment include:
- Over-the-Counter (OTC) Medications: Painkillers, cold and flu remedies, digestive aids, and allergy medications consistently rank high. Consumers appreciate the discretion and comparative pricing.
- Dermocosmetics and Skincare: Specialized skincare products, often recommended by pharmacists, find a significant market online due to wider availability and detailed product information.
- Health Supplements and Vitamins: A broad category including dietary supplements, vitamins, minerals, and herbal remedies. Consumers frequently research and purchase these items online.
- Medical Devices and Aids: Products such as blood pressure monitors, thermometers, bandages, and rehabilitation aids are increasingly purchased online for convenience.
- Baby and Child Care Products: Diapers, baby formula, specialized creams, and other infant care items represent a stable segment.
The average frequency of online pharmacy purchases per user per year was estimated at 3.2 times in 2024, with a slight increase to 3.5 times projected for 2025. This suggests a growing habituation among consumers to integrate online channels into their regular health product procurement.
Regulatory Framework Impacting Digital Sales
The digital retail of pharmacy products in Austria operates within a stringent regulatory environment, primarily governed by the Arzneimittelgesetz (AMG) and specific provisions concerning distance selling. These regulations significantly shape the scope and operational modalities for online pharmacies.
Key regulatory aspects include:
- Prescription-Only Medicines (Rx): The sale of prescription-only medications via mail order (Versandhandel) or online channels is generally prohibited in Austria. This fundamental restriction means that the vast majority of the Austrian pharmacy market’s value, which is in Rx drugs, remains exclusively with physical pharmacies. This contrasts with some other EU countries where regulated online sales of Rx drugs are permitted.
- Non-Prescription Medicines (OTC): The online sale of non-prescription (rezeptfreie) medications is permissible, provided the selling entity adheres to Austrian or relevant EU regulations, including proper licensing and quality assurance standards. Austrian pharmacies offering online sales must be registered with the Gesundheitsministerium and adhere to specific requirements for packaging, information, and safe delivery.
- Distance Selling (Fernabsatzgesetz): General consumer protection laws regarding distance selling apply, ensuring rights such as withdrawal periods and transparent pricing.
- Advertising Restrictions: Advertising for medicinal products, particularly online, is subject to strict rules to prevent misleading claims and promote responsible use.
- Cross-Border Sales: While Austrian law restricts local online Rx sales, EU law generally permits cross-border online sales of non-prescription drugs from pharmacies legally established in other EU member states, provided they comply with their home country’s regulations and certain EU directives. This facilitates the operation of many pure-play online pharmacies serving the Austrian market from Germany or the Netherlands, for example.
The current regulatory landscape effectively segments the market, limiting the digital channel to non-prescription items and thus influencing the product mix and market share dynamics observed. Any future regulatory shifts regarding prescription drug sales online would fundamentally alter the market structure and growth potential.
Frequently Asked Questions
What is the projected online pharmacy market size in Austria for 2025? The estimated market volume for digital pharmacy retail in Austria, excluding prescription medications, is projected to reach €245 Million by 2025. This represents a 16.7% increase from the €210 Million estimated for 2024.
What is the online penetration rate for pharmacy retail in Austria by 2025? The online penetration of total pharmacy retail revenue in Austria is projected to reach 6.2% by 2025. This marks an increase of 0.8 percentage points from the 5.4% estimated for 2024, indicating a sustained shift towards digital channels.
Can prescription drugs be purchased online in Austria? No, the sale of prescription-only medications (Rx) via mail order or online channels is generally prohibited in Austria. This regulatory restriction means that the vast majority of the Austrian pharmacy market’s value, which is in Rx drugs, remains exclusively with physical pharmacies.
Which types of online pharmacies dominate the Austrian market? EU cross-border online pharmacies are projected to hold the largest market share in Austria’s digital pharmacy retail, with 64% in 2025. Austrian traditional pharmacies with online sales are expected to account for 29%, while other retailers make up 7%.
What are the top-selling product categories in Austrian online pharmacies? Top-selling product categories include Over-the-Counter (OTC) Medications, Dermocosmetics and Skincare, Health Supplements and Vitamins, Medical Devices and Aids, and Baby and Child Care Products. Consumers are driven by convenience, broader selection, and often comparative pricing for these items.
For deeper strategic analysis, see our full report.
By 2025, the Austrian digital pharmacy retail market is projected to reach a volume of €245 Million, achieving an online penetration of 6.2% of total pharmacy retail. This expansion is predominantly within the non-prescription segment, as current regulatory frameworks continue to prohibit the online sale of prescription medications.
PREMIUM REPORT
Get the Full Strategic Breakdown
The free data above is just the surface. Our premium report includes margin analysis, competitive playbooks, and actionable growth strategies.
- Complete margin analysis by category and country
- Competitive playbook with specific company strategies
- Growth projections through Q4 2026
- Regulatory compliance checklist for DACH markets
- Supplier negotiation benchmarks
Senior E-Commerce Analysts
Quantis Intel Research Team
The Quantis Intel research team analyses e-commerce markets across Germany, Austria, and Switzerland. Our data-driven reports combine proprietary metrics with public market data to deliver actionable insights for DACH retailers and brands.